Ultomiris Drug Market: Revolutionizing Complement Inhibition Therapy
The biopharmaceutical landscape is rapidly evolving with the introduction of innovative therapies designed to tackle complex diseases at their root cause. Among these groundbreaking treatments, Ultomiris (ravulizumab), developed by AstraZeneca’s Alexion Pharmaceuticals, has emerged as a game-changing therapy in...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek